Enlivex Therapeutics (ENLV)
(Delayed Data from NSDQ)
$1.03 USD
0.00 (0.00%)
Updated Sep 26, 2025 04:00 PM ET
After-Market: $1.03 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth A Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Enlivex Therapeutics Ltd.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ENLV 1.03 0.00(0.00%)
Will ENLV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ENLV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ENLV
Enlivex Therapeutics (ENLV) Upgraded to Strong Buy: Here's What You Should Know
New Strong Buy Stocks for October 23rd
ENLV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ENLV
ENLV forms Narrow Range Bar on September 27
Is ENLV gaining bearish strength? 20 Day Moving Average Resistance shows up after declining 1.44%
ENLV: D. Boral Capital Maintains Buy Rating with $13 Price Target Today | ENLV Stock News
Enlivex Therapeutics Announces Annual General Meeting for November 2025
ENLV forms 20 Day Moving Average Resistance on September 23